<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00728832</url>
  </required_header>
  <id_info>
    <org_study_id>SKY0401-016</org_study_id>
    <nct_id>NCT00728832</nct_id>
  </id_info>
  <brief_title>A Pharmacokinetic (PK) Study of Extended-Release Epidural Morphine in Upper Abdominal Surgery</brief_title>
  <official_title>A Phase 1 Study to Evaluate the Effects of Lidocaine/Epinephrine Test Dose Administration on the Pharmacokinetic Profile of a Single Dose of Thoracic Extended-Release Epidural Morphine in Patients Undergoing Major Upper Abdominal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EKR Therapeutics, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pacira Pharmaceuticals, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>EKR Therapeutics, Inc</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to evaluate the effects of lidocaine/epinephrine test
      dose administration on the PK profile of a single epidural dose of DepoDur (extended-release
      epidural morphine) in patients undergoing major upper abdominal surgery. A secondary
      objective was to evaluate the safety and efficacy profile.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2002</start_date>
  <primary_completion_date type="Actual">February 2003</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the serum pharmacokinetic profile of a single 15-mg dose of DepoDur administered at the lower thoracic epidural space with or without a prior lidocaine-epinephrine test dose</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>efficacy and safety profiles</measure>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>No test dose + DepoDur + flush with 1 mL normal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test dose + flush with 1 mL normal saline + 3-minute wait + DepoDur + flush with 1 mL normal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test dose + flush with 1 mL normal saline + 10-minute wait + DepoDur + flush with 1 mL normal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test dose + flush with 1 mL normal saline + 15-minute wait + DepoDur + flush with 1 mL normal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test dose + No flush + 3-minute wait + DepoDur + flush with 1 mL normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DepoDur (extended-release epidural morphine)</intervention_name>
    <description>DepoDur with on demand boluses of IV fentanyl PCA</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <arm_group_label>5</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females ≥ 18 years of age at Screening

          -  Negative pregnancy test in females of childbearing potential

          -  Scheduled for major upper abdominal surgery via an upper midline incision under
             general anesthesia

          -  American Society of Anesthesiology (ASA) Physical Class 1, 2, or 3

          -  Willing and able to use a PCA pump

          -  Willing to receive only IV fentanyl for 72 hours post-dose to control post-operative
             pain

          -  Capable of providing written informed consent and responses to pain assessment scales
             and neurological assessment questionnaires

        Exclusion Criteria:

          -  Morbid obesity, defined as a body mass index (BMI) ≥ 40

          -  Scheduled to undergo surgery under regional anesthesia

          -  Usage of analgesic medications containing morphine or codeine within three days prior
             to study drug administration

          -  Chronic opioid medication usage (defined as daily opioids for more than 7 days prior
             to enrollment)

          -  Suspected or documented history of sleep apnea, narcolepsy, or excessive daytime
             sleepiness

          -  Female who was pregnant or lactating

          -  History of hypersensitivity or idiosyncratic reaction to opioid medications, local
             anesthetics, or epinephrine

          -  Any contraindication for the epidural administration of study drug (e.g.,
             coagulopathy, local infection)

          -  Administration of an investigational drug within 30 days prior to Screening

          -  Suspected or documented history of substance abuse and/or alcoholism

          -  Any contraindication to frequent blood PK sampling (such as significant anemia) or
             other barrier to obtaining timely PK samples
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eugene R Viscusi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thomas Jefferson University</affiliation>
  </overall_official>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2008</study_first_submitted>
  <study_first_submitted_qc>August 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2008</study_first_posted>
  <last_update_submitted>August 12, 2008</last_update_submitted>
  <last_update_submitted_qc>August 12, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 14, 2008</last_update_posted>
  <responsible_party>
    <name_title>Eugene R. Viscusi, MD</name_title>
    <organization>Thomas Jefferson University</organization>
  </responsible_party>
  <keyword>extended release epidural morphine</keyword>
  <keyword>morphine</keyword>
  <keyword>thoracic epidural</keyword>
  <keyword>pharmacokinetics</keyword>
  <keyword>pharmacodynamics</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>upper abdominal surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

